KERSTEN GEERT R 4 Filing

From the Filing

EDGAR Filing Documents for 0001236030-26-000003 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001236030-26-000003 Filing Date 2026-04-01 Accepted 2026-04-01 06:59:38 Documents 1 Period of Report 2026-03-31 Document Format Files Seq Description Document Type Size 1 PRIMARY DOCUMENT primary_doc.html 4 1 PRIMARY DOCUMENT primary_doc.xml 4 3089 Complete submission text file 0001236030-26-000003.txt 4622 Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182 Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460 CEL SCI CORP ( Issuer ) CIK : 0000725363 (see all company filings) EIN. : 840916344 | State of Incorp.: CO | Fiscal Year End: 0930 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences) Mailing Address 8229 BOONE BLVD STE 802 VIENNA VA 22182 Business Address KERSTEN GEERT R ( Reporting ) CIK : 0001236030 (see all company filings) Type: 4 | Act: 34 | File No.: 001-11889 | Film No.: 26824643